mna-715 and Diabetes-Mellitus--Type-1

mna-715 has been researched along with Diabetes-Mellitus--Type-1* in 2 studies

Other Studies

2 other study(ies) available for mna-715 and Diabetes-Mellitus--Type-1

ArticleYear
Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
    Transplantation proceedings, 2001, Volume: 33, Issue:3

    Topics: Alkynes; Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mice; Mice, Inbred NOD; Nitriles; Rats; Transplantation, Heterologous

2001
Generation of O2- radicals in macrophages can be inhibited in vitro and in vivo by derivatives of leflunomide's primary metabolite.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1999, Volume: 48 Suppl 2

    Topics: Acrylamides; Alkynes; Animals; Caproates; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Free Radicals; Humans; Immunosuppressive Agents; Isoxazoles; Macrophages; Mice; Mice, Inbred NOD; Nitriles; Superoxides

1999